Innohep and Escitalopram drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Innohep and Escitalopram. Common interactions include gamma-glutamyltransferase increased among females and dyskinesia among males.

The phase IV clinical study analyzes what interactions people who take Innohep and Escitalopram have. It is created by eHealthMe based on reports of 64 people who take Innohep and Escitalopram from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

64 people who take Innohep and Escitalopram together, and have interactions are studied.


What is Innohep?

Innohep has active ingredients of tinzaparin sodium. eHealthMe is studying from 8,216 Innohep users for its effectiveness, alternative drugs and more.

What is Escitalopram?

Escitalopram has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 62,458 Escitalopram users for its effectiveness, alternative drugs and more.

Number of Innohep and Escitalopram reports submitted per year:

Innohep and Escitalopram drug interactions.

Common Innohep and Escitalopram drug interactions by gender *:

female:

  1. Gamma-glutamyltransferase increased
  2. Gastritis
  3. Gastrointestinal toxicity
  4. Haemoglobin decreased
  5. Hepatitis cholestatic
  6. Hyperkalaemia
  7. Hypoalbuminaemia
  8. Hyponatraemia
  9. Hypophagia
  10. Hypothyroidism

male:

  1. Dyskinesia
  2. Pleural effusion
  3. Supraventricular tachycardia
  4. General physical health deterioration
  5. Acute respiratory distress syndrome
  6. Diarrhoea
  7. Epistaxis
  8. Mouth haemorrhage
  9. Musculoskeletal stiffness
  10. Respiratory tract infection

Common Innohep and Escitalopram drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Gastrointestinal toxicity

30-39:

n/a

40-49:

  1. Diarrhoea
  2. Haemoglobin decreased
  3. Phlebitis
  4. Rectal haemorrhage

50-59:

  1. Pulmonary embolism
  2. Pulmonary thrombosis
  3. Spinal cord infection
  4. Spondylitis
  5. Urine output decreased
  6. Urticaria
  7. Eczema
  8. Sepsis
  9. Abdominal pain upper
  10. Alanine aminotransferase increased

60+:

  1. Confusional state
  2. Dyspnoea
  3. Pneumatosis intestinalis
  4. Sepsis
  5. Acute respiratory distress syndrome
  6. Bicytopenia
  7. Cholestasis
  8. Diarrhoea
  9. Erythema
  10. Facial bones fracture

Common conditions people have *:

  1. Anaemia (lack of blood): 13 people, 20.31%
  2. High Blood Pressure: 13 people, 20.31%
  3. Pulmonary Embolism (blockage of the main artery of the lung): 13 people, 20.31%
  4. Acute Kidney Failure: 10 people, 15.62%
  5. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 10 people, 15.62%
  6. Stress And Anxiety: 9 people, 14.06%
  7. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 8 people, 12.50%
  8. Pain: 7 people, 10.94%
  9. Lung Neoplasm Malignant (cancer tumour of lung): 6 people, 9.38%
  10. Heparin-Induced Thrombocytopenia: 6 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take Innohep and Escitalopram?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Innohep and Escitalopram interactions:

Browse all drug interactions of Innohep and Escitalopram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Innohep side effects:

Browse all side effects of Innohep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Escitalopram side effects:

Browse all side effects of Escitalopram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Innohep interactions:

Browse all interactions between Innohep and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Escitalopram interactions:

Browse all interactions between Escitalopram and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tinzaparin sodium and escitalopram oxalate (the active ingredients of Innohep and Escitalopram, respectively), and Innohep and Escitalopram (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Innohep and Escitalopram.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: